GMAB Stock Predictions

Recent GMAB Stock Price   GMAB Stock Predictions
$43.12 GMAB stock predictions: higher
+3.90%
$44.80
 As of 2021-09-19
Recent GMAB Analyst Ratings Breakdown, Making GMAB Stock Predictions
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 2 4 4 4
Buy ratings: 0 0 0 1
Hold ratings: 3 2 2 2
Sell ratings: 0 0 0 0
Strong sell ratings: 1 0 0 0
Average rating: 2.55 1.67 1.67 1.71
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

For the GMAB stock predictions from the analysts covering Genmab A/S, we have collected all of the individual GMAB stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering GMAB (as reported in data provided by Zacks Investment Research via Quandl.com).

But since GMAB stock predictions may vary widely, another useful metric to consider is the median GMAB stock prediction, which represents the price at which half of the analysts made GMAB stock predictions that were higher and half made GMAB stock predictions that were lower. This makes for a different take on the GMAB stock predictions out there, as compared to average or mean. And that median across all the individual GMAB stock predictions was: $47.0 as of 2021-09-19.

The very highest of the GMAB stock predictions for one year price target was $50.0, while the very lowest of the GMAB stock predictions in the analyst group was $37.0 (with a standard deviation of $5.263). Get the latest Zacks research report on GMAB — FREE


Slideshow Dividend Growth Stocks: 25 Aristocrats
Slideshow 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did



Other stock predictions:
 • ILMN Stock Predictions
 • ENR Stock Predictions
 • FTI Stock Predictions
 • RDI Stock Predictions
 • FRGI Stock Predictions
 • PFE Stock Predictions
 • CHT Stock Predictions
 • REKR Stock Predictions
 • PPBI Stock Predictions

Name: 
Genmab A/S
Website: 
www.genmab.com
Sector: 
Biotechnology
Quotes delayed 20 minutes

Hold (2.45 out of 4)
7th percentile
(ranked lower than approx. 93% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com


 
 

GMAB Stock Predictions | www.TopDividends.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in this site or parent site DividendChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.